Three Lupus Nephritis Patients Show Early BCMA CAR T Responses

Company IASO Bio Event Type Investigator-initiated data disclosure Modality Autologous BCMA CAR T Asset Equecabtagene autoleucel (eque-cel) Target BCMA Disease Area Refractory lupus nephritis Summary Recovered source-gap item: IASO Bio disclosed November 10 investigator-initiated data in three severe refractory lupus nephritis patients with nine months…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *